<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03725930</url>
  </required_header>
  <id_info>
    <org_study_id>2016_37</org_study_id>
    <secondary_id>2017-003638-10</secondary_id>
    <nct_id>NCT03725930</nct_id>
  </id_info>
  <brief_title>Premedication by Clonidine Intranasal in Pediatric Surgery</brief_title>
  <acronym>CLONIPREM</acronym>
  <official_title>Premedication by Clonidine Intranasal in Pediatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are few studies using intra nasal way to dispense premedication in pediatrics.

      This study will evaluate anxiolysis effect of Intranasal premedication with Clonidine vs
      Placebo.

      Two groups, randomized,

      Total of 150 patients (75 in each group) :

      Involvement in study for one patient : 7 days Duration of study including inclusion and data
      analysis : 18 months (inclusion 12 months; data analysis 6 months)
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anxiolysis score</measure>
    <time_frame>at 30 minutes after premedication</time_frame>
    <description>Anxiolysis score (1 : Anxious, crying; 2 : Anxious; 3 : Calm, not cooperative; 4 : Calm, cooperative</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acceptation of mask at the induction of anesthesia</measure>
    <time_frame>1 hour after premedication</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Agitation score after the extubation</measure>
    <time_frame>15 min after extubation</time_frame>
    <description>Agitation score : 0 : Patient</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Child Preschool</condition>
  <arm_group>
    <arm_group_label>Clonidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm will receive intra nasal Clonidine as a premedication before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This arm will receive intra nasal Placebo as a premedication before surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clonidine</intervention_name>
    <description>clonidine intranasal premedication in preschool infants</description>
    <arm_group_label>Clonidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo intranasal premedication</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Child from 1 to 5 years

          2. Weight between 10 to 25 kgs

          3. Scheduled minor surgery

          4. Oral and written information and consent given by main investigator to both of the
             parents or legal(s) representative(s).

          5. ASA score 1 or 2

          6. Patient with social care insurance

        Exclusion Criteria:

          1. Refusal of one of the parental authority or legal representing

          2. Concomitant participation to a clinical trial with use of a drug

          3. Known hypersensitivity or contraindication to Clonidine or one of its excipients

          4. Airway infection within 3 weeks before inclusion

          5. Intravenous induction of anesthesia

          6. Antecedent of arrhythmia or congenital heart disease

          7. Mental disorder or current psychoactive medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dina BERT, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dina BERT, MD</last_name>
    <phone>3 20 44 60 69</phone>
    <phone_ext>+33</phone_ext>
    <email>dina.bert@chru-lille.fr</email>
  </overall_contact>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>October 29, 2018</study_first_submitted>
  <study_first_submitted_qc>October 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2018</study_first_posted>
  <last_update_submitted>July 10, 2019</last_update_submitted>
  <last_update_submitted_qc>July 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>paediatric</keyword>
  <keyword>premedication</keyword>
  <keyword>clonidine</keyword>
  <keyword>intranasal</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clonidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

